1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Sickle Cell Disease Treatment Demonstration Program is sponsored by Health Resources and Services Administration (HRSA). The purpose of this program is to increase access for individuals with SCD to quality, coordinated, comprehensive care by increasing the number of knowledgeable clinicians, improving the quality of care, and improving care coordination with other providers.
Get alerted about grants like this
Get emailed when new opportunities from “Health Resources and Services Administration (HRSA)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
## View Grant Opportunity Sickle Cell Disease Regional Care Excellence (SoRCE) Program Department of Health and Human Services Health Resources and Services Administration Document Type:Grants Notice Funding Opportunity Number:HRSA-26-052 Funding Opportunity Title:Sickle Cell Disease Regional Care Excellence (SoRCE) Program Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Category of Funding Activity:Health Expected Number of Awards:7 Assistance Listings:93.
365 -- Sickle Cell Treatment Demonstration Program Cost Sharing or Matching Requirement:No Last Updated Date:Jun 05, 2026 Original Closing Date for Applications:Jul 08, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Current Closing Date for Applications:Jul 08, 2026 Electronically submitted applications must be submitted no later than 11:59 p. m. , ET, on the listed application due date.
Archive Date:Aug 30, 2026 Estimated Total Program Funding:$ 6,650,000 Eligible Applicants:Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Additional Information on Eligibility:Hospitals or clinicsHealth centers.
## Additional Information Agency Name:Health Resources and Services Administration Description:Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD.
Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment.
As these children become adolescents and transition to adulthood many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH).
Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care. Link to Additional Information:[](https://www. grants.
gov/search-results-detail/360997) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact:
According to the current listing, eligibility includes: Federally-qualified health centers, nonprofit hospitals or clinics, or university health centers that provide primary healthcare and have a collaborative agreement with a community-based sickle cell disease organization…. Confirm the full requirements in the official notice before applying.
Sickle Cell Disease Treatment Demonstration Program is funded by Health Resources and Services Administration (HRSA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The FY2026 Rural Health Network Advancement Program (HRSA-26-082) offers six awards of roughly $500,000 to help independent rural hospitals and clinics form integrated networks without surrendering local ownership. With a July 24, 2026 deadline and a pilot design that rewards genuine collaboration over merger, here is who qualifies, what a fundable network looks like, and how small rural providers should approach it.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read articleHRSA-26-078 splits $9.1 million among roughly 10 Public Health Training Centers, with awards up to $910,000 and applications due July 17, 2026. Eligibility runs to accredited schools of public health and other nonprofit training institutions. Here's why the winning applications are the ones that can prove an existing, mapped relationship with state and local health departments — not the ones promising the slickest coursework.
Read article